Good Clinical Practices
-
Upload
karun-kumar -
Category
Education
-
view
393 -
download
0
Transcript of Good Clinical Practices
![Page 1: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/1.jpg)
GOOD CLINICAL PRACTICES
DR. KARUN KUMAR
JUNIOR RESIDENT – I
DEPT. OF PHARMACOLOGY
![Page 2: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/2.jpg)
What is Clinical Research ?
•Research conducted on•Human subjects or •Material of human origin •Tissues, •Specimens, and •Cognitive phenomena
http://keck.usc.edu/Research/Clinical_Research/Definition.aspx
![Page 3: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/3.jpg)
What is Clinical Trial ?
•Scientific studies
•Test the effectiveness of •Treatment, •Device, or•Drug
•Find new & better wayshttp://keck.usc.edu/en/Research/Clinical_Research/Clinical_Trials.aspx
![Page 4: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/4.jpg)
Phases of Clinical Trial
Phase Primary goal Dose Patient monitorNumber of
participants
Preclinical
Testing of drug in non-human subjects
UnrestrictedA graduate level researcher-Ph.D.
In vitro & in vivo animal models
Phase 0Oral bioavailability & half-life of drug
SubtherapeuticClinical researcher
10 people
Phase ITesting of drug on healthy volunteers (safety)
Subtherapeuticwith asc. Doses
Clinical researcher
20-100
Phase IITesting of drug on patients (efficacy & tolerability)
Therapeutic doseClinical researcher
100-300
Phase IIITesting of drug on pts.(confirm efficacy)
Therapeutic doseClinical research.& Physician
1000-2000
Phase IVPost-marketing surveillance (A/E, D-D I)
Therapeutic dose PhysicianAnyone seeking treatment
Phase V Translational research No dosing None All reported use
DeMets D., Friedman, L., and Furberg, C.,(2010).Fundamentals of Clinical Trials.Springer 4th EditionGoodman and Gilman's The Pharmacological Basis of Therapeutics, (2011) 12th Edition
![Page 5: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/5.jpg)
![Page 6: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/6.jpg)
What are Good Clinical Practices ?
•More than any one document •Collective compilation of many • thoughts, • ideas and• learning moments
spanning the globe over
![Page 7: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/7.jpg)
•International ethical and scientific quality standard for •Design,•Conduct, •Performance, •Monitoring, •Auditing, •Recording, •Analysis, and •Reporting
of clinical trials
![Page 8: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/8.jpg)
Historical BackgroundYear Event
460 B.C. Oath of Hippocrates
1930's U.S. Food, Drugs and Cosmetic Act
1947 Nuremberg Code
Dec. 10th 1948 Declaration of Human Rights
1962 Kefauver-Harris Amendment
1964 Declaration of Helsinki
1979 The Belmont Report
1982 International Guidelines for Biomedical Research Involving Human Subjects (WHO & CIOMS)
1996 ICH-GCP guidelines issued
1997 ICH-GCP guidelines implemented
Vijayananthan A, Nawawi O.The importance of Good Clinical Practice guidelines and its role in clinical trials.Biomed Imaging Interv J. 2008 Jan-Mar; 4(1).
![Page 9: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/9.jpg)
![Page 10: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/10.jpg)
![Page 11: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/11.jpg)
![Page 12: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/12.jpg)
The death sentences imposed in October 1946 were carried out by Master Sergeant John C. Woods (1903-50), who told a reporter from Time magazine that he was proud of his work. "The way I look at this hanging job, somebody has to do it . . . ten men in 103 minutes. That's fast work."
http://www.history.com/topics/world-war-ii/nuremberg-trials
![Page 13: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/13.jpg)
Brigadier General Telford Taylor, Chief of Counsel, during the Doctors Trial, which was held in Nuremberg, Germany, from December 9, 1946, to August 20, 1947.
![Page 14: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/14.jpg)
During testimony at the Doctors Trial, American medical expert Dr. Leo Alexander points to scars on Jadwiga Dzido’s leg. Dzido, a member of the Polish underground, was a victim of medical experiments at the Ravensbrüeck concentration camp. Nuremberg, Germany, December 22, 1946.
![Page 15: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/15.jpg)
Nazi physician Carl Clauberg who performed medical experiments on prisoners in Block 10 of the Auschwitz camp. Poland, between 1941 and 1944.
![Page 16: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/16.jpg)
A prisoner in a compression chamber loses consciousness (and later dies) during an experiment to determine altitudes at which aircraft crews could survive without oxygen. Dachau, Germany, 1942.
![Page 17: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/17.jpg)
Victim of a medical experiment immersed in freezing water at the Dachau concentration camp. Dachau, Germany, between August 1942 and May 1943.
![Page 18: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/18.jpg)
A Romani (Gypsy) victim of Nazi medical experiments to make seawater potable. Dachau concentration camp, Germany, 1944.
![Page 19: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/19.jpg)
Photo of wounds left by a medical experiment. The victim had been burned with phosphorous so that medicaments could be tested
![Page 20: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/20.jpg)
Nuremberg Code (1947)
•Voluntary consent of the human subject is absolutely essential
•Favorable risk/benefit ratio
•Research must help society
•Research should be based on previous knowledge
![Page 21: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/21.jpg)
•Participant must be free to stop at any time
•Research should not cause mental & physical suffering
•Research should avoid risk of injury & death
![Page 22: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/22.jpg)
![Page 23: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/23.jpg)
Declaration of Helsinki (1964)
•Well being of subject > interest of science & society
•Consent should be in writing
•Limited use of placebo
•Greater access to benefit
![Page 24: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/24.jpg)
(April, 1979)
![Page 25: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/25.jpg)
![Page 26: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/26.jpg)
Respect for persons
•Protecting autonomy of subjects
•Treating subjects with courtesy and respect
•Allowing for informed consent
![Page 27: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/27.jpg)
Beneficence
•The philosophy of "Do no harm”
•Maximize benefits for the research project
•Minimize risks to the research subjects
![Page 28: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/28.jpg)
Justice
•Ensure considered procedures are administered fairly
•Fair distribution between•Burden of research (Costs)•Benefit of research
![Page 29: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/29.jpg)
Common Rule (1981)
•Describes the types of research subject(s)
•Defines key terms such as •Research, •Human subject, and •Minimal risk
![Page 30: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/30.jpg)
•Sets forth requirements for •IRB membership•Review procedures•Criteria for approval
•Lists requirements for informed consent
![Page 31: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/31.jpg)
Overview of Clinical research process
Development of the trial protocol
Development of standard operating procedures (SOPs)
Development of support systems and tools
![Page 32: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/32.jpg)
Selection of trial sites and the selection of properly qualified, trained, and experienced investigators and study personnel
Ethics committee review & approval of the protocol
Enrollment of subjects into the study:-
Recruitment,
Eligibility, &
Informed consent
Review by regulatory authorities
![Page 33: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/33.jpg)
Safety management and reporting
Trial data acquisition: conducting the trial
The investigational product(s): quality, handling and accounting
Monitoring the trial
![Page 34: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/34.jpg)
Quality assurance of the trial performance and data
Managing trial data
Reporting the trial
![Page 35: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/35.jpg)
WHO principles for GCP
Principle 1 – Ethical Conduct
•Research involving humans Scientifically sound
In accordance with Declaration of Helsinki
![Page 36: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/36.jpg)
Principle 2: Protocol
•Research
To be described in a •Clear,•Detailed, and•“Scientifically justified” protocol
![Page 37: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/37.jpg)
Principle 3: Risk Identification
•Foreseeable risks and discomforts and any anticipated benefit(s)
To be identified
![Page 38: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/38.jpg)
Principle 4: Benefit-Risk Assessment
•Research initiated only if anticipated benefit(s) outweigh the risks
•Most important considerations•Rights,•Safety, and•Well-being of trial subjects
![Page 39: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/39.jpg)
Principle 5: Review by IEC/IRB
•Research should receive independent (IEC/IRB) approval prior to initiation
![Page 40: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/40.jpg)
Principle 6: Protocol Compliance
•Research Conducted in compliance with the approved protocol
![Page 41: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/41.jpg)
Principle 7: Informed Consent
•To be obtained •From every subject •Prior to research participation •In accordance with national culture(s) and requirements
![Page 42: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/42.jpg)
Principle 8: Continuing review / ongoing benefit-risk assessment
•Research Continued only if the benefit-risk profile remains favorable
![Page 43: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/43.jpg)
Principle 9: Investigator Qualifications
•Qualified and duly licensedmedical personnel Responsible for the
medical care of trial subjects
![Page 44: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/44.jpg)
Principle 10: Staff Qualifications
•Each individual involved should be qualified by•Education, •Training, and•Experience
![Page 45: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/45.jpg)
Principle 11: Records
•Clinical trial information should be •Recorded,•Handled, and •Stored
![Page 46: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/46.jpg)
•In a way that allows its accurate
•Reporting,
•Interpretation, and
•Verification
![Page 47: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/47.jpg)
Principle 12: Confidentiality / Privacy
•Confidentiality of records should be protected
•In accordance with the applicable regulatory requirement(s)
![Page 48: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/48.jpg)
Principle 13: Good Manufacturing Practice(s)
•Investigational products should be •Manufactured, •Handled, and •Stored
in accordance with applicable GMP
![Page 49: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/49.jpg)
Principle 14: Quality Systems
•Systems with procedures that assure the quality of every aspect of the trial should be implemented •Quality control (QC)•Quality assurance (QA)•Quality improvement (QI)
![Page 50: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/50.jpg)
Code of Federal Regulations, Title 21
21 CFR 11: Electronic records and signatures
21 CFR 50: Protection of human subjects
21 CFR 54: Financial disclosure by clinical investigators
![Page 51: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/51.jpg)
21 CFR 56: IRB that oversee clinical trials
21 CFR 312: Investigational New Drug Application
21 CFR 812: Investigational Device Exemptions
![Page 52: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/52.jpg)
![Page 53: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/53.jpg)
ICH-GCP guidelines
•“Bible” of clinical trials
•Global law which safeguards humanity
•13 core principles
![Page 54: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/54.jpg)
Who is responsible for GCP ?
•Each & every person involved in the research process.
•This includes
1.Sponsors
2.Investigators and research staff
![Page 55: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/55.jpg)
3. Contract Research Organizations
4. IRB/EC
5. FDA
6. Research Subject
![Page 56: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/56.jpg)
Never ending debate
•Whether the "greater good" trumps the rights of the individual?
•Are individual’s rights what make up the greater good?
•Is it the greater good that allows for individual’s rights?
![Page 57: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/57.jpg)
Take Home Message
•"If it wasn't documented, it wasn't done.”
•GCP is more than a piece of paper or a set of rules
•A mind-set of dedication that ensures a high level of ethics & quality in research
![Page 58: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/58.jpg)
![Page 59: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/59.jpg)
![Page 60: Good Clinical Practices](https://reader031.fdocuments.in/reader031/viewer/2022032419/55a2d8961a28ab977d8b467f/html5/thumbnails/60.jpg)
THANK YOU